Congregational Health Network communications, collaboration, information, and support
These ingredients lack any clinical trial studies proving they match the metabolic effects of prescription GLP-1 drugs
Lilys SURMOUNT-OSA trial will begin in March 2024 to evaluate the effect of Mounjaro on sleep apnea
As of December 2025, Medicare does not cover GLP-1s for weight loss, and several state Medicaid programs rolled back coverage in 2025
Real-world results vary based on starting weight, adherence, lifestyle factors, and individual response
As the molecules in PGN are too short to form helices, PGN administered in drinking water will always be in the random coil conformation even at concentrations as high as 5%